67 related articles for article (PubMed ID: 21358112)
21. Antitumor effect of hepatocyte growth factor on hepatoblastoma.
Tsunoda Y; Shibusawa M; Tsunoda A; Gomi A; Yatsuzuka M; Okamatsu T
Anticancer Res; 1998; 18(6A):4339-42. PubMed ID: 9891489
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma.
Jiménez-Rivera C; Avitzur Y; Fecteau AH; Jones N; Grant D; Ng VL
Pediatr Transplant; 2004 Jun; 8(3):243-8. PubMed ID: 15176961
[TBL] [Abstract][Full Text] [Related]
23. Treatment-related acute myelomonocytic leukemia with t(11;19) in a child following chemotherapy for hepatoblastoma.
Koga Y; Matsuzaki A; Suminoe A; Washitoh N; Hara T; Hara T; Tajiri T; Taguchi T
Pediatr Blood Cancer; 2008 Apr; 50(4):943-4. PubMed ID: 17973320
[No Abstract] [Full Text] [Related]
24. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases.
Tang Y; Taylor RR; Gonzalez MV; Lewis AL; Stratford PW
J Control Release; 2006 Nov; 116(2):e55-6. PubMed ID: 17718969
[No Abstract] [Full Text] [Related]
25. Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.
Fuchs CS; Moore MR; Harker G; Villa L; Rinaldi D; Hecht JR
J Clin Oncol; 2003 Mar; 21(5):807-14. PubMed ID: 12610178
[TBL] [Abstract][Full Text] [Related]
26. Hepatoblastoma and hypoplastic kidneys: a new association.
Chan R; Mascarenhas L; Venkatramani R
Pediatr Blood Cancer; 2014 Aug; 61(8):1476-8. PubMed ID: 24623570
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical evaluation of the activity of irinotecan as a basis for regional chemotherapy.
Hofmann C; Buttenschoen K; Straeter J; Henne-Bruns D; Kornmann M
Anticancer Res; 2005; 25(2A):795-804. PubMed ID: 15868911
[TBL] [Abstract][Full Text] [Related]
28. Complete resection of unresectable liver metastases from colorectal cancer without deterioration of liver function after cetuximab and irinotecan: two case reports.
Karasaki T; Sano K; Takamoto T; Kinoshita H; Tateishi R; Takemura T; Makuuchi M
Hepatogastroenterology; 2010; 57(104):1526-8. PubMed ID: 21443115
[TBL] [Abstract][Full Text] [Related]
29. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy.
van Hazel GA; Pavlakis N; Goldstein D; Olver IN; Tapner MJ; Price D; Bower GD; Briggs GM; Rossleigh MA; Taylor DJ; George J
J Clin Oncol; 2009 Sep; 27(25):4089-95. PubMed ID: 19652069
[TBL] [Abstract][Full Text] [Related]
30. A pair of sulfur-containing geldanamycin analogs, 19-S-methylgeldanamycin and 4,5-dihydro- 19-S-methylgeldanamycin, from Streptomyces hygroscopicus 17997.
Liu X; Li J; Ni S; Wu L; Wang H; Lin L; He W; Wang Y
J Antibiot (Tokyo); 2011 Jul; 64(7):519-22. PubMed ID: 21559026
[No Abstract] [Full Text] [Related]
31. Hepatic tumors in children.
Newman KD
Semin Pediatr Surg; 1997 Feb; 6(1):38-41. PubMed ID: 9117273
[TBL] [Abstract][Full Text] [Related]
32. [Resection of liver metastasis of colorectal origin following chemotherapy with irinotecan].
Adam R
Ann Chir; 2004 Mar; 129 Spec No 2():2-4. PubMed ID: 15255013
[No Abstract] [Full Text] [Related]
33. Successful response to cidofovir of adenovirus hepatitis during chemotherapy in a child with hepatoblastoma.
Mateos ME; López-Laso E; Pérez-Navero JL; Peña MJ; Velasco MJ
J Pediatr Hematol Oncol; 2012 Oct; 34(7):e298-300. PubMed ID: 22935664
[TBL] [Abstract][Full Text] [Related]
34. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue.
Kobrinsky NL; Sjolander DE; Goldenberg JA; Ortmeier TC
Pediatr Blood Cancer; 2005 Aug; 45(2):222-5. PubMed ID: 15770640
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by an angiogenesis inhibitor, TNP-470, of the growth of a human hepatoblastoma heterotransplanted into nude mice.
Matsusaka S; Nakasho K; Terada N; Sugihara A; Tsujimura T; Takanashi T; Uematsu K; Okamoto E; Toyosaka A
J Pediatr Surg; 2000 Aug; 35(8):1198-204. PubMed ID: 10945693
[TBL] [Abstract][Full Text] [Related]
37. Reversible grade 4 hyperbilirubinemia in a patient with UGT1A1 7/7 genotype treated with irinotecan and cetuximab.
Gupta B; LeVea C; Litwin A; Fakih MG
Clin Colorectal Cancer; 2007 Mar; 6(6):447-9. PubMed ID: 17531109
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of Patients With Relapsed Hepatoblastoma Enrolled on Children's Oncology Group (COG) Phase I and II Studies.
Trobaugh-Lotrario AD; Meyers RL; Feusner JH
J Pediatr Hematol Oncol; 2016 Apr; 38(3):187-90. PubMed ID: 26583620
[TBL] [Abstract][Full Text] [Related]
39. Neonatal hepatoblastoma: two cases posing a diagnostic dilemma, with a review of the literature.
Sallam A; Paes B; Bourgeois J
Am J Perinatol; 2005 Nov; 22(8):413-9. PubMed ID: 16283600
[TBL] [Abstract][Full Text] [Related]
40. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
